Free press releases distribution network?

Agency / Source: Sterilex Corporation

Twitter @NewswireTODAY
Check Ads Availability|e-mail Article
This article was published free of charge. Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Sterilex Corporation Appoints Mark E. Wozniak, Ph. D. as Director of Research and Development - Sterilex today announces that Mark E. Wozniak, Ph. D. has been appointed Director of Research and Development, effective immediately
Sterilex Corporation Appoints Mark E. Wozniak, Ph. D. as Director of Research and Development

 

PRZOOM - /newswire/ - Owings Mills, MD, United States, 2008/02/21 - Sterilex today announces that Mark E. Wozniak, Ph. D. has been appointed Director of Research and Development, effective immediately.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Prior to joining Sterilex, Dr. Wozniak held a variety of positions at J.M. Huber Corporation including Director of Quality and Senior R&D Manager. Dr. Wozniak is a proven leader in directing R&D initiatives and has experience guiding process improvement initiatives, leading business transformations and overhauling manufacturing procedures. At Sterilex, Dr. Wozniak will guide Sterilex’s R&D initiatives into safer, more effective anti-biofilm and antimicrobial technologies. He received his Bachelor of Science degree in Chemistry from the University of Michigan and his Ph. D. in Inorganic Chemistry from The Pennsylvania State University.

“We are very excited that Dr. Wozniak will be leading Sterilex’s innovation programs, and we look forward to working with him to continue Sterilex’s commitment to the development of innovative solutions for microbial control.” said Dr. Shira Kramer, President of Sterilex.

“I am honored by the opportunity to join the strong team at Sterilex and look forward to helping Sterilex develop innovative solutions that fortify its leadership position in markets it services.” Dr. Wozniak said.

About Sterilex Corporation
Sterilex Corporation (sterilex.com) is a leader in developing patented antimicrobial and anti-biofilm products for infection control, the decontamination of pathogens, spoilage organisms and resistant biofilms. The Sterilex product line includes EPA-registered antimicrobial products for biofilm and pathogen control, as well as specialty cleaning and decontaminating agents. Sterilex sells disinfectants, anti-biofilm biocides, cleaning, and decontaminating products to the health care, dental care, water care, industrial, food processing, and environmental remediation industries.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Sterilex Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sterilex Corporation Appoints Mark E. Wozniak, Ph. D. as Director of Research and Development

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Alex Josowitz - Sterilex.com 
800-511-1659 alex[.]sterilex.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sterilex Corporation securities in any jurisdiction including any other companies listed or named in this release.

PRTODAY NewswirePharma/BioTech/Nutrition via RSS
AddThis press release: Sterilex Corporation Appoints Mark E. Wozniak, Ph. D. as Director of Research and DevelopmentAdd Pharma/BioTech/Nutrition News to My MSNAdd Pharma/BioTech/Nutrition News to My Yahoo!Add NewswireToday Pharma/BioTech/Nutrition Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner

This article was published free of charge. Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Sterilex Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

IPSEN Announces Second Resupply of Increlex® (mecasermin [rDNA origin] Injection) in the U.S in 2014
BTG and SciClone Announce That DC Bead® Has Been Approved by China Food and Drug Administration
Pathology Diagnostics Ltd Contributes As Expert Advisor to Groundbreaking MRC Review
DPx Holdings B.V. Reaches Definitive Agreement to Acquire Gallus BioPharmaceuticals
Sciformix to Showcase Next Generation Pharmacovigilance Approaches at the World Drug Safety Congress Europe
Patheon Announces Launch of Updated Quick to Clinic™ Program
inGenious Targeting Laboratory Scores Contracts for Use of Innovative TruHumanization™ Technology
First Varicose Vein Patient Treated with FDA-Approved Varithena® (polidocanol injectable foam) 1%
Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy
Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Institute of Computer Vision/ Comp. Sciences

Visit  NAKIVO, Inc.

Visit  BizJobs.com







 
  ©2014 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today